サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1658984

脱パイロジェン滅菌空バイアルの世界市場レポート 2025年

Depyrogenated Sterile Empty Vials Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
脱パイロジェン滅菌空バイアルの世界市場レポート 2025年
出版日: 2025年02月18日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

脱パイロジェン滅菌空バイアルの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で52億5,000万米ドルに成長します。この予測期間における成長は、先進ドラッグデリバリーシステムへの注目、容器密封の完全性に対する規制の重点化、個別化医療へのアプローチの増加、バイオ製造施設の拡大、持続可能な包装への注目、サプライチェーン管理のデジタル化、バリューチェーンが高いがん治療薬への需要などに起因しています。予測期間の主な動向には、使い捨て技術、生物学的医薬品開発、Quality by Design（QBD）アプローチ、生分解性で持続可能な材料、サプライチェーン管理のデジタル化、スマート包装技術、無菌充填技術の進歩、共同研究やパートナーシップなどが含まれます。

世界的な感染症の流行増加は、脱パイロジェン滅菌空バイアル市場の成長を促進すると予想されます。感染症は、細菌、ウイルス、寄生虫、真菌などの有害な微生物によって引き起こされる疾患です。脱パイロジェン滅菌バイアルは、これらの感染症の治療に関わる注射薬の保管に使用されます。さらに、脱パイロジェン滅菌空バイアルは実験室サンプルの採取にも利用されます。例えば、2024年2月、英国の政府機関である健康安全保障局は、2023年のイングランドにおける結核患者数が2022年と比較して10.7％増加したと報告しました。患者数は2022年の4,380人から2023年には4,850人に増加しました。その結果、世界的な感染症有病率の増加が脱パイロジェン滅菌空バイアル市場の成長を押し上げると予想されます。

高齢者人口の増加は、今後の脱パイロジェン滅菌空バイアル市場の成長を促進すると予測されます。高齢者人口とは65歳以上の高齢者を指します。脱パイロジェン滅菌空バイアルは、特に高齢者において発熱やその他の副作用を引き起こす可能性のある発熱反応のリスクを低減し、薬剤の安全性を確保し、感染を予防するために使用されます。例えば、米国を拠点とする保健専門機関である世界保健機関（WHO）によると、2022年10月、2030年までに世界の6人に1人が60歳以上になり、この年齢層の人口は2050年までに21億人に倍増します。さらに2021年6月、英国を拠点とする情報資源である英国議会の下院図書館によると、2043年までに英国の高齢者人口は増加し、総人口の24％（1,740万人）を占めると予想されています。したがって、高齢者人口の増加が脱パイロジェン滅菌空バイアル市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の脱パイロジェン滅菌空バイアル市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の脱パイロジェン滅菌空バイアル市場：成長率分析
  • 世界の脱パイロジェン滅菌空バイアル市場の実績：規模と成長、2019～2024年
  • 世界の脱パイロジェン滅菌空バイアル市場の予測：規模と成長、2024～2029年、2034年
  • 世界の脱パイロジェン滅菌空バイアル総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の脱パイロジェン滅菌空バイアル市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
  • 2ML
  • 5ML
  • 10ML
  • 20ML
  • 20ML以上
  • 世界の脱パイロジェン滅菌空バイアル市場：包装別、実績と予測、2019～2024年、2024～2029年、2034年
  • ガラス
  • プラスチック
  • 世界の脱パイロジェン滅菌空バイアル市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
  • 臨床検査室
  • 調合ラボ
  • 製薬会社
  • CMO
  • 販売代理店
  • 世界の脱パイロジェン滅菌空バイアル市場：2MLのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 使い捨てバイアル
  • マルチドーズバイアル
  • 世界の脱パイロジェン滅菌空バイアル市場：5MLのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 使い捨てバイアル
  • マルチドーズバイアル
  • 世界の脱パイロジェン滅菌空バイアル市場：10MLのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 使い捨てバイアル
  • マルチドーズバイアル
  • 世界の脱パイロジェン滅菌空バイアル市場：20MLのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 使い捨てバイアル
  • マルチドーズバイアル
  • 世界の脱パイロジェン滅菌空バイアル市場：20ML以上のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 使い捨てバイアル
  • マルチドーズバイアル

第7章 地域別・国別分析

  • 世界の脱パイロジェン滅菌空バイアル市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界の脱パイロジェン滅菌空バイアル市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 脱パイロジェン滅菌空バイアル市場：競合情勢
  • 脱パイロジェン滅菌空バイアル市場：企業プロファイル
    • APG Pharma Overview, Products and Services, Strategy and Financial Analysis
    • Corning Inc. Overview, Products and Services, Strategy and Financial Analysis
    • DWK Life Sciences Overview, Products and Services, Strategy and Financial Analysis
    • Nipro PharmaPackaging Overview, Products and Services, Strategy and Financial Analysis
    • Schott AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Thermo Fisher Scientific
  • Gerresheimer AG
  • Stevanato Group
  • SGD Pharma
  • Merck KGaA
  • SiO2 Materials Science
  • Shandong Pharmaceutical Glass Co. Ltd.
  • West Pharmaceutical Services Inc.
  • Ompi Srl
  • AptarGroup Inc.
  • Pacific Vial Manufacturing Inc.
  • Adelphi Healthcare Packaging Limited
  • Acme Vial and Glass Company LLC
  • Amposan S.A.
  • BMT Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 脱パイロジェン滅菌空バイアル市場2029年：新たな機会を提供する国
  • 脱パイロジェン滅菌空バイアル市場2029年：新たな機会を提供するセグメント
  • 脱パイロジェン滅菌空バイアル市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r22525

Depyrogenated sterile empty vials are borosilicate glass containers equipped with butyl-rubber stoppers and aluminum seals, designed for the storage of injectable drugs. Depyrogenation is a process that involves the removal of pyrogenic substances, including bacterial endotoxins, through the application of heat.

The main product types of depyrogenated sterile empty vials include 2 ml, 5 ml, 10 ml, 20 ml, and those exceeding 20 ml in volume. For example, a 2 ml vial refers to a container with a volume of 2 milliliters, commonly used for injectable drug storage. These vials are available in standard and large opening variations, typically used with aluminum seals. Depyrogenated sterile empty vials come in glass and plastic packaging, serving the needs of clinical labs, compounding labs, pharmaceutical companies, contract manufacturing organizations, and distributors.

The depyrogenated sterile empty vials market research report is one of a series of new reports from The Business Research Company that provides depyrogenated sterile empty vials market statistics, including depyrogenated sterile empty vials industry global market size, regional shares, competitors with a depyrogenated sterile empty vials market share, detailed depyrogenated sterile empty vials market segments, market trends and opportunities, and any further data you may need to thrive in the depyrogenated sterile empty vials industry. This depyrogenated sterile empty vials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The depyrogenated sterile empty vials market size has grown strongly in recent years. It will grow from $3.63 billion in 2024 to $3.83 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rise in pharmaceutical manufacturing, stringent regulatory standards, focus on drug stability and purity, increase in contract manufacturing, expansion of clinical trials, introduction of high-value biologics, focus on patient safety, shift towards ready-to-use components.

The depyrogenated sterile empty vials market size is expected to see strong growth in the next few years. It will grow to $5.25 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to focus on advanced drug delivery systems, increasing regulatory emphasis on container closure integrity, rise in personalized medicine approaches, expansion of biomanufacturing facilities, focus on sustainable packaging, digitalization of supply chain management, demand for high-value oncology drugs. Major trends in the forecast period include single-use technologies, biological drug development, quality by design (QBD) approaches, biodegradable and sustainable materials, digitalization in supply chain management, smart packaging technologies, advancements in aseptic filling technologies, collaborations and partnerships,.

The rising prevalence of infectious diseases worldwide is expected to drive the growth of the depyrogenated sterile empty vials market. Infectious diseases are conditions caused by harmful microorganisms such as bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials are used for storing injectable medications involved in the treatment of these infectious diseases. Furthermore, depyrogenated sterile empty vials are also utilized for collecting laboratory samples. For example, in February 2024, the Health Security Agency, a UK-based government agency, reported a 10.7% increase in tuberculosis (TB) cases in England in 2023 compared to 2022. The number of cases grew from 4,380 in 2022 to 4,850 in 2023. As a result, the increasing prevalence of infectious diseases globally is expected to boost the growth of the depyrogenated sterile empty vials market.

The increase in the geriatric population is expected to drive the growth of the depyrogenated sterile empty vials market in the future. The geriatric population refers to elderly individuals aged 65 years and older. Depyrogenated sterile empty vials are used in this population to ensure medication safety and prevent infections, reducing the risk of pyrogenic reactions, which can cause fever and other adverse effects, particularly in older individuals. For example, in October 2022, according to the World Health Organization, a US-based specialized health agency, 1 in 6 people globally will be 60 or older by 2030, and the number of individuals in this age group will double to 2.1 billion by 2050. Additionally, in June 2021, according to the UK Parliament's House of Commons Library, a UK-based information resource, by 2043, the senior population in the UK is expected to rise, making up 24% of the total population (17.4 million people). Therefore, the growing geriatric population is fueling the growth of the depyrogenated sterile empty vials market.

Technological advancements have become a key trend gaining traction in the depyrogenated sterile empty vials market. Leading companies in the market are focusing on integrating advanced technologies into depyrogenated sterile empty vials to improve quality and maintain their competitive position. For example, in November 2022, Gerresheimer AG, a Germany-based drug packaging company, in collaboration with Stevanato Group S.p.A., an Italy-based provider of drug containment, delivery, and diagnostic solutions, launched the EZ-fill Smart platform. This new Ready-To-Fill solution for the global vial market aims to enhance drug packaging quality, lower total cost of ownership (TCO), and reduce lead times for customers. As an evolution of Stevanato Group's pioneering EZ-fill platform, EZ-fill Smart introduces key improvements that can significantly enhance customer product offerings, addressing the increasing demand for ready-to-use vials.

Leading companies in the depyrogenated sterile empty vials market are focusing on product innovation, such as Ready-to-Use (RTU) sterile 100 ml molded glass vials, to gain a competitive advantage. These vials are specifically designed for packaging high-value parenteral drugs in large volumes. For example, in March 2022, SGD Pharma, an India-based company specializing in glass pharmaceutical packaging services, launched Ready-to-Use (RTU) sterile 100 ml molded glass vials. These vials feature no glass-to-glass contact, reducing particle generation to enhance patient safety. They are compatible with various injectable applications and are sterile and depyrogenated, ensuring they are free from contaminants.

In June 2023, ALK-Abello, Inc., a pharmaceutical company based in Denmark known for manufacturing sterile empty vials, entered into a strategic partnership with Galenova Inc., a Canada-based pharmaceutical company. Through this collaboration, ALK-Abello, Inc. aims to enhance its distribution network by providing dependable and high-quality glass vials to pharmacies and hospitals throughout Canada. Galenova Inc. specializes in pharmaceutical products, including the provision of depyrogenated sterile empty vials. This partnership reflects a joint effort to strengthen the supply chain and deliver essential pharmaceutical components to the Canadian healthcare system.

Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, AptarGroup Inc., Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Ciron Drugs & Pharmaceuticals Pvt. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd., Verpakkingsindustrie B.V.,

North America was the largest region in the depyrogenated sterile empty vials market in 2024. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the depyrogenated sterile empty vials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The depyrogenated sterile empty vials market consists of sales of type I borosilicate glass, and molded and tabular glass depyrogenated sterile empty vials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Depyrogenated Sterile Empty Vials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on depyrogenated sterile empty vials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for depyrogenated sterile empty vials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The depyrogenated sterile empty vials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: 2 ML; 5 ML; 10 ML; 20 ML; >20 ML
  • 2) By Packaging: Glass; Plastic
  • 3) By End User: Clinical Labs; Compounding Labs; Pharmaceutical Companies; Contract Manufacturing Organization; Distributors
  • Subsegments:
  • 1) By 2 ML: Single-Use Vials; Multi-Dose Vials
  • 2) By 5 ML: Single-Use Vials; Multi-Dose Vials
  • 3) By 10 ML: Single-Use Vials; Multi-Dose Vials
  • 4) By 20 ML: Single-Use Vials; Multi-Dose Vials
  • 5) By >20 ML: Single-Use Vials; Multi-Dose Vials
  • Companies Mentioned: APG Pharma; Corning Inc.; DWK Life Sciences; Nipro PharmaPackaging; Schott AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Depyrogenated Sterile Empty Vials Market Characteristics

3. Depyrogenated Sterile Empty Vials Market Trends And Strategies

4. Depyrogenated Sterile Empty Vials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Depyrogenated Sterile Empty Vials Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Depyrogenated Sterile Empty Vials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Depyrogenated Sterile Empty Vials Market Growth Rate Analysis
  • 5.4. Global Depyrogenated Sterile Empty Vials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Depyrogenated Sterile Empty Vials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Depyrogenated Sterile Empty Vials Total Addressable Market (TAM)

6. Depyrogenated Sterile Empty Vials Market Segmentation

  • 6.1. Global Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 2 ML
  • 5 ML
  • 10 ML
  • 20 ML
  • >20 ML
  • 6.2. Global Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glass
  • Plastic
  • 6.3. Global Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Labs
  • Compounding Labs
  • Pharmaceutical Companies
  • Contract Manufacturing Organization
  • Distributors
  • 6.4. Global Depyrogenated Sterile Empty Vials Market, Sub-Segmentation Of 2 ML, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Vials
  • Multi-Dose Vials
  • 6.5. Global Depyrogenated Sterile Empty Vials Market, Sub-Segmentation Of 5 ML, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Vials
  • Multi-Dose Vials
  • 6.6. Global Depyrogenated Sterile Empty Vials Market, Sub-Segmentation Of 10 ML, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Vials
  • Multi-Dose Vials
  • 6.7. Global Depyrogenated Sterile Empty Vials Market, Sub-Segmentation Of 20 ML, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Vials
  • Multi-Dose Vials
  • 6.8. Global Depyrogenated Sterile Empty Vials Market, Sub-Segmentation Of >20 ML, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Vials
  • Multi-Dose Vials

7. Depyrogenated Sterile Empty Vials Market Regional And Country Analysis

  • 7.1. Global Depyrogenated Sterile Empty Vials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Depyrogenated Sterile Empty Vials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Depyrogenated Sterile Empty Vials Market

  • 8.1. Asia-Pacific Depyrogenated Sterile Empty Vials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Depyrogenated Sterile Empty Vials Market

  • 9.1. China Depyrogenated Sterile Empty Vials Market Overview
  • 9.2. China Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Depyrogenated Sterile Empty Vials Market

  • 10.1. India Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Depyrogenated Sterile Empty Vials Market

  • 11.1. Japan Depyrogenated Sterile Empty Vials Market Overview
  • 11.2. Japan Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Depyrogenated Sterile Empty Vials Market

  • 12.1. Australia Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Depyrogenated Sterile Empty Vials Market

  • 13.1. Indonesia Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Depyrogenated Sterile Empty Vials Market

  • 14.1. South Korea Depyrogenated Sterile Empty Vials Market Overview
  • 14.2. South Korea Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Depyrogenated Sterile Empty Vials Market

  • 15.1. Western Europe Depyrogenated Sterile Empty Vials Market Overview
  • 15.2. Western Europe Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Depyrogenated Sterile Empty Vials Market

  • 16.1. UK Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Depyrogenated Sterile Empty Vials Market

  • 17.1. Germany Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Depyrogenated Sterile Empty Vials Market

  • 18.1. France Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Depyrogenated Sterile Empty Vials Market

  • 19.1. Italy Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Depyrogenated Sterile Empty Vials Market

  • 20.1. Spain Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Depyrogenated Sterile Empty Vials Market

  • 21.1. Eastern Europe Depyrogenated Sterile Empty Vials Market Overview
  • 21.2. Eastern Europe Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Depyrogenated Sterile Empty Vials Market

  • 22.1. Russia Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Depyrogenated Sterile Empty Vials Market

  • 23.1. North America Depyrogenated Sterile Empty Vials Market Overview
  • 23.2. North America Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Depyrogenated Sterile Empty Vials Market

  • 24.1. USA Depyrogenated Sterile Empty Vials Market Overview
  • 24.2. USA Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Depyrogenated Sterile Empty Vials Market

  • 25.1. Canada Depyrogenated Sterile Empty Vials Market Overview
  • 25.2. Canada Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Depyrogenated Sterile Empty Vials Market

  • 26.1. South America Depyrogenated Sterile Empty Vials Market Overview
  • 26.2. South America Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Depyrogenated Sterile Empty Vials Market

  • 27.1. Brazil Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Depyrogenated Sterile Empty Vials Market

  • 28.1. Middle East Depyrogenated Sterile Empty Vials Market Overview
  • 28.2. Middle East Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Depyrogenated Sterile Empty Vials Market

  • 29.1. Africa Depyrogenated Sterile Empty Vials Market Overview
  • 29.2. Africa Depyrogenated Sterile Empty Vials Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Depyrogenated Sterile Empty Vials Market, Segmentation By Packaging, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Depyrogenated Sterile Empty Vials Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Depyrogenated Sterile Empty Vials Market Competitive Landscape And Company Profiles

  • 30.1. Depyrogenated Sterile Empty Vials Market Competitive Landscape
  • 30.2. Depyrogenated Sterile Empty Vials Market Company Profiles
    • 30.2.1. APG Pharma Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Corning Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. DWK Life Sciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Nipro PharmaPackaging Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Schott AG Overview, Products and Services, Strategy and Financial Analysis

31. Depyrogenated Sterile Empty Vials Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific
  • 31.2. Gerresheimer AG
  • 31.3. Stevanato Group
  • 31.4. SGD Pharma
  • 31.5. Merck KGaA
  • 31.6. SiO2 Materials Science
  • 31.7. Shandong Pharmaceutical Glass Co. Ltd.
  • 31.8. West Pharmaceutical Services Inc.
  • 31.9. Ompi Srl
  • 31.10. AptarGroup Inc.
  • 31.11. Pacific Vial Manufacturing Inc.
  • 31.12. Adelphi Healthcare Packaging Limited
  • 31.13. Acme Vial and Glass Company LLC
  • 31.14. Amposan S.A.
  • 31.15. BMT Corporation

32. Global Depyrogenated Sterile Empty Vials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Depyrogenated Sterile Empty Vials Market

34. Recent Developments In The Depyrogenated Sterile Empty Vials Market

35. Depyrogenated Sterile Empty Vials Market High Potential Countries, Segments and Strategies

  • 35.1 Depyrogenated Sterile Empty Vials Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Depyrogenated Sterile Empty Vials Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Depyrogenated Sterile Empty Vials Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer